Fredy Omar Beltrán‐Anaya

Author

National Institute of Genomic Medicine ORCID

Also Known As

Beltran-Anaya, Fredy Omar, F. Beltrán-Anaya, Fredy Beltran‑Anaya, Fredy O. Beltran‐Anaya, Fredy O. Beltrán-Anaya, Fredy Omar Beltran-Anaya, Fredy Omar Beltrán-Anaya, Fredy Omar Beltrán‐Anaya

Publications

519

Citations

H-Index

Concepts

All Affiliations

National Institute of Genomic Medicine Universidad Nacional Autónoma de México Universidad Autónoma de Guerrero Instituto Nacional de Cancerología Mexican Social Security Institute

About

Fredy Omar Beltrán‐Anaya is an author at National Institute of Genomic Medicine specializing in cancer genetics, medicine, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	115
2	Cell Biology	3	3	81
3	Pathology	2	2	73
4	Molecular Genetics	1	1	34
5	Cancer Cell Biology	1	1	30

Fredy Omar Beltrán‐Anaya

Publications

351

Citations

H-Index

Page 1

	Year	Citations
New insights into radioresistance in breast cancer identify a dual function of miR‐122 as a tumor suppressor and oncomiR Isidro X. Perez‐Añorve, Claudia Haydée González-De la Rosa, Ernesto Soto‐Reyes, Molecular Oncology	2019	66
The EPIYA-ABCC motif pattern in CagA of Helicobacter pyloriis associated with peptic ulcer and gastric cancer in Mexican population Fredy Omar Beltrán‐Anaya, Tomás Manuel Poblete, Adolfo Román-Román, BMC Gastroenterology	2014	42
Changes in global gene expression profiles induced by HPV 16 E6 oncoprotein variants in cervical carcinoma C33-A cells Ana Elvira Zacapala-Gómez, Óscar Del Moral-Hernández, Nicolás Villegas‐Sepúlveda, Virology Systems BiologyCervical CancerHuman Papillomavirus VaccinesHpv16 VariantsExpression Vector	2015	39
Mitochondrial DNA Mutation Analysis in Breast Cancer: Shifting From Germline Heteroplasmy Toward Homoplasmy in Tumors Carlos Jhovani Pérez-Amado, Hugo Tovar, Laura Gómez-Romero, Frontiers in Oncology Tumor BiologyOncologyCancer PathologySomatic VariantTumor Heterogeneity	2020	34
A lncRNA landscape in breast cancer reveals a potential role for AC009283.1 in proliferation and apoptosis in HER2-enriched subtype Alberto Cedro‐Tanda, M. Rios-Romero, Sandra Romero‐Córdoba, Scientific Reports	2020	33
Expression of long non‐coding <scp>RNA ENSG</scp>00000226738 (Lnc<scp>KLHDC</scp>7B) is enriched in the immunomodulatory triple‐negative breast cancer subtype and its alteration promotes cell migration, invasion, and resistance to cell death Fredy Omar Beltrán‐Anaya, Sandra Romero‐Córdoba, Rosa Rebollar‐Vega, Molecular Oncology Tumor BiologyTranscriptional RegulationAlteration PromotesMedicineCancer Cell Biology	2019	30
Transcriptome Analysis Identifies LINC00152 as a Biomarker of Early Relapse and Mortality in Acute Lymphoblastic Leukemia Diego Alberto Bárcenas-López, Juan Carlos Núñez-Enríquez, Alfredo Hidalgo‐Miranda, Genes	2020	30
Population and breast cancer patients’ analysis reveals the diversity of genomic variation of the BRCA genes in the Mexican population Juan Carlos Fernández-López, Sandra Romero‐Córdoba, Rosa Rebollar‐Vega, Human Genomics	2019	24
Functional Integrity and Gene Expression Profiles of Human Cord Blood-Derived Hematopoietic Stem and Progenitor Cells Generated In Vitro Roberto Dircio-Maldonado, Patricia Flores-Guzmán, Julieta Corral-Navarro, Stem Cells Translational Medicine	2018	17
SFRP1 increases TMPRSS2-ERG expression promoting neoplastic features in prostate cancer in vitro and in vivo Carlos D. Cruz-Hernández, Marian Cruz-Burgos, Sergio A. Cortés-Ramírez, Cancer Cell International	2020	13

Page 1